Holdings of the Fund as of 12/17/2025
Total Number of Holdings (excluding cash): 50
| Johnson & Johnson |
JNJ |
478160104 |
Pharmaceuticals |
6,868 |
$1,444,546.44 |
7.41% |
| Merck & Co., Inc. |
MRK |
58933Y105 |
Pharmaceuticals |
14,466 |
$1,434,737.88 |
7.36% |
| Bristol-Myers Squibb Company |
BMY |
110122108 |
Pharmaceuticals |
25,792 |
$1,381,161.60 |
7.08% |
| AbbVie Inc. |
ABBV |
00287Y109 |
Pharmaceuticals |
5,784 |
$1,297,409.04 |
6.65% |
| Pfizer Inc. |
PFE |
717081103 |
Pharmaceuticals |
49,146 |
$1,230,615.84 |
6.31% |
| Eli Lilly and Company |
LLY |
532457108 |
Pharmaceuticals |
831 |
$865,727.49 |
4.44% |
| Cardinal Health, Inc. |
CAH |
14149Y108 |
Pharmaceuticals |
4,089 |
$811,421.16 |
4.16% |
| Regeneron Pharmaceuticals, Inc. |
REGN |
75886F107 |
Biotechnology |
1,048 |
$785,779.92 |
4.03% |
| Biogen Inc. |
BIIB |
09062X103 |
Biotechnology |
4,518 |
$777,547.80 |
3.99% |
| Vertex Pharmaceuticals Incorporated |
VRTX |
92532F100 |
Pharmaceuticals |
1,556 |
$699,453.12 |
3.59% |
| United Therapeutics Corporation |
UTHR |
91307C102 |
Pharmaceuticals |
1,362 |
$695,900.28 |
3.57% |
| Amgen Inc. |
AMGN |
031162100 |
Pharmaceuticals |
2,115 |
$689,511.15 |
3.54% |
| Viatris Inc. |
VTRS |
92556V106 |
Pharmaceuticals |
57,671 |
$674,750.70 |
3.46% |
| Gilead Sciences, Inc. |
GILD |
375558103 |
Pharmaceuticals |
5,386 |
$653,644.96 |
3.35% |
| Zoetis Inc. |
ZTS |
98978V103 |
Pharmaceuticals |
3,890 |
$475,552.50 |
2.44% |
| Jazz Pharmaceuticals Plc |
JAZZ |
G50871105 |
Pharmaceuticals |
2,862 |
$471,986.74 |
2.42% |
| Illumina, Inc. |
ILMN |
452327109 |
Biotechnology |
3,031 |
$392,696.36 |
2.01% |
| PTC Therapeutics, Inc. |
PTCT |
69366J200 |
Biotechnology |
4,347 |
$325,764.18 |
1.67% |
| Incyte Corporation |
INCY |
45337C102 |
Biotechnology |
3,078 |
$300,505.14 |
1.54% |
| Charles River Laboratories International, Inc. |
CRL |
159864107 |
Biotechnology |
1,492 |
$292,402.16 |
1.50% |
| Exelixis, Inc. |
EXEL |
30161Q104 |
Biotechnology |
6,062 |
$254,604.00 |
1.31% |
| Arrowhead Pharmaceuticals, Inc. |
ARWR |
04280A100 |
Biotechnology |
3,760 |
$243,648.00 |
1.25% |
| Medpace Holdings, Inc. |
MEDP |
58506Q109 |
Biotechnology |
406 |
$226,170.42 |
1.16% |
| Elanco Animal Health Incorporated |
ELAN |
28414H103 |
Pharmaceuticals |
9,423 |
$208,059.84 |
1.07% |
| BioMarin Pharmaceutical Inc. |
BMRN |
09061G101 |
Pharmaceuticals |
3,555 |
$184,149.00 |
0.94% |
| Halozyme Therapeutics, Inc. |
HALO |
40637H109 |
Biotechnology |
2,315 |
$152,257.55 |
0.78% |
| Ionis Pharmaceuticals, Inc. |
IONS |
462222100 |
Pharmaceuticals |
1,943 |
$149,766.44 |
0.77% |
| Alkermes Plc |
ALKS |
G01767105 |
Pharmaceuticals |
5,140 |
$144,125.60 |
0.74% |
| Amneal Pharmaceuticals, Inc. |
AMRX |
03168L105 |
Pharmaceuticals |
11,357 |
$140,031.81 |
0.72% |
| Neurocrine Biosciences, Inc. |
NBIX |
64125C109 |
Biotechnology |
947 |
$134,189.90 |
0.69% |
| Krystal Biotech, Inc. |
KRYS |
501147102 |
Biotechnology |
561 |
$132,283.80 |
0.68% |
| Protagonist Therapeutics, Inc. |
PTGX |
74366E102 |
Biotechnology |
1,403 |
$125,344.02 |
0.64% |
| Insmed Incorporated |
INSM |
457669307 |
Biotechnology |
609 |
$120,862.14 |
0.62% |
| BridgeBio Pharma, Inc. |
BBIO |
10806X102 |
Biotechnology |
1,600 |
$118,432.00 |
0.61% |
| Guardant Health, Inc. |
GH |
40131M109 |
Biotechnology |
1,228 |
$119,693.16 |
0.61% |
| NewAmsterdam Pharma Company N.V. |
NAMS |
N62509109 |
Biotechnology |
3,444 |
$115,993.92 |
0.59% |
| Madrigal Pharmaceuticals, Inc. |
MDGL |
558868105 |
Biotechnology |
189 |
$103,229.91 |
0.53% |
| Catalyst Pharmaceuticals, Inc. |
CPRX |
14888U101 |
Biotechnology |
4,137 |
$99,288.00 |
0.51% |
| Ligand Pharmaceuticals Inc. (Class B) |
LGND |
53220K504 |
Biotechnology |
512 |
$99,630.08 |
0.51% |
| Corcept Therapeutics Inc. |
CORT |
218352102 |
Pharmaceuticals |
1,188 |
$97,748.64 |
0.50% |
| ADMA Biologics, Inc. |
ADMA |
000899104 |
Biotechnology |
4,798 |
$90,346.34 |
0.46% |
| Rhythm Pharmaceuticals, Inc. |
RYTM |
76243J105 |
Biotechnology |
803 |
$89,823.58 |
0.46% |
| Supernus Pharmaceuticals, Inc. |
SUPN |
868459108 |
Pharmaceuticals |
1,836 |
$89,505.00 |
0.46% |
| TG Therapeutics, Inc. |
TGTX |
88322Q108 |
Biotechnology |
2,824 |
$87,911.12 |
0.45% |
| ACADIA Pharmaceuticals Inc. |
ACAD |
004225108 |
Biotechnology |
3,187 |
$85,825.91 |
0.44% |
| Prestige Consumer Healthcare Inc. |
PBH |
74112D101 |
Pharmaceuticals |
1,295 |
$80,704.40 |
0.41% |
| Mirum Pharmaceuticals, Inc. |
MIRM |
604749101 |
Biotechnology |
1,121 |
$77,349.00 |
0.40% |
| Alnylam Pharmaceuticals, Inc. |
ALNY |
02043Q107 |
Biotechnology |
185 |
$72,538.50 |
0.37% |
| Tempus AI, Inc. (Class A) |
TEM |
88023B103 |
Biotechnology |
1,092 |
$70,559.58 |
0.36% |
| Perrigo Company Plc |
PRGO |
G97822103 |
Pharmaceuticals |
4,521 |
$60,400.56 |
0.31% |
| US Dollar |
$USD |
|
Other |
25,022 |
$25,021.75 |
0.13% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|